RECRUITING

Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

Talk to us

Conditions

No Restrictions on Diagnosis

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical research protocol is intended to allow for bone marrow aspirate/biopsy and blood specimens to be collected for research purposes, specifically allowing subjects the option of sedation during the bone marrow procedure. Samples will be banked for future research related to cancer and other diseases. Researchers hope this protocol will improve the collection of research correlative and translational biopsy specimens for clinical research.

Official Title

Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

Quick Facts

Study Start:2010-02-01
Study Completion:2025-05-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT01985919

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Planned procedure including a bone marrow aspirate and/or bone marrow biopsy
  2. * The procedure is planned for the purpose of obtaining a research specimen (as part of another research study or as part of this stand-alone sample collection protocol.). Procedures with a dual purpose (i.e. to obtain both clinically-indicated specimens and research specimens) are permitted, but procedures to obtain clinical specimens only are not permitted.
  3. * All subjects must provide written informed consent for the biopsy procedure, the collection of bone marrow and blood specimens for research purposes and (if planned) the administration of sedation.
  1. * Moderate sedation may not be administrated to subjects with a clinical contraindication to its provision, or if the investigator believes that administration of moderate sedation would constitute under risk to the subject.

Contacts and Locations

Study Contact

Dan Vogl, MD
CONTACT
855-216-0098
PennCancerTrials@emergingmed.com

Principal Investigator

Dan Vogl, MD
PRINCIPAL_INVESTIGATOR
Abramson Cancer Center

Study Locations (Sites)

Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: Abramson Cancer Center at Penn Medicine

  • Dan Vogl, MD, PRINCIPAL_INVESTIGATOR, Abramson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2010-02-01
Study Completion Date2025-05-07

Study Record Updates

Study Start Date2010-02-01
Study Completion Date2025-05-07

Terms related to this study

Additional Relevant MeSH Terms

  • No Restrictions on Diagnosis